<DOC>
	<DOCNO>NCT02623231</DOCNO>
	<brief_summary>Testing effect provide antidepressant anxiety-type escitalopram patient glioblastoma patient 's quality life include effect treatment mood cognition treatment.Two subgroup fill questionnaire : - Questionnaire mini mental state exam ( mmse ) maximum score 30 . A score 24 indicate flaw level dementia - Questionnaire depression / mood PHQ9P ( Pa e n H e l h Qu e n n r e - 9 ) - The M. D. Anderson Symptom Inventory ( MDASI ) - Evaluation hospital situation awareness ( clinical assessment questionnaire ) - Cognitive assessment carry Department neuropsychological include : - Executive function ( Stroop ) - Abstract Reasoning ( similarity ) - -Auditory Spatial Attention ( Digit span , Spatial span ) visual memory remember Literature - Memory function - visual auditory ( ROCF , RAVLT ) - Language function : Naming verbal fluency - Mindstreems Neurotrax</brief_summary>
	<brief_title>The Effect Escitalopram Mood , Quality Life Cognitive Functioning Glioblastoma Patients</brief_title>
	<detailed_description>This study plan prospective randomized , control , double-blind study . Patients undergo resection biopsy glioblastoma ( newly diagnose glioblastoma ) , randomization ratio 1 : 1 pharmacist ( age , Karnofsky score , extent tumor resection ) , two research group : Group number 1 include 50 patient , receive Escitalopram Placebo dose 10 mg week exceed 20 mg immediately diagnosis 3 month . . The dose study fix aim symptomatic treatment anti-depressant ( major depression ) .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>* men woman Aged 1880 sign inform consent form patient underwent biopsy resection brain glioblastoma . KPSâ‰¥70 Patients stable term seizure take one antiepileptic drug Patients suffer depression within five year , Patients treat antidepressant Are able answer questionnaire inability communicate Patients treat inhibitor ( MAOI ) : nialamide , isocarboxazid , iproniazid , phenerzine , tranylcypromine Patients suffer epilepsy . Patients suffer Parkinson 's Patients suffer cardiac dysfunction heart attack recently . Patients eye problem expand pupil result development glaucoma close angle . Severe renal dysfunction . ( creatinine clearance &lt; 30 mL / min ) . , Creatinine le 1.5 time upper limit normal endstage renal disease Hepatic insufficiency bilirubin General &gt; 1.5 time upper limit normal , Hepatic Enzymes le 2.5 time upper limit normal Pregnant woman score less 24 test The minimental state examination ( MMSE ) allergy component drug Talc , croscarmellose sodium , Microcrystalline Cellulose silicified , Magnesium stearate , Hypromellose , Macrogol 400 , Titanium Dioxide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>